Intended use:

For in vitro diagnostic use. RIDA®QUICK Malaria is an immunochromatographic rapid test to qualitatively detect Plasmodium falciparum (P.f.), Plasmodium vivax (P.v.), Plasmodium ovale (P.o.) and Plasmodium malariae (P.m.) antigens in whole blood. It is intended for the quick diagnosis of malaria as soon as the first clinical symptoms appear.

General Information:

In many tropical countries, malaria is still a serious problem and in a few regions it is even a growing problem. A distinction is made between three different types of malaria. The most dangerous is the form caused by the Plasmodium falciparum pathogen. Known as malaria tropica, this form is almost exclusively responsible for the deaths and accounts for the majority of the malaria diseases imported to the industrial countries. The pathogens of the other types of malaria are Plasmodium vivax and Plasmodium ovale (malaria tertiana) as well as Plasmodium malariae (malaria quartana).

The common standard method for the minimal diagnosis of malaria in a laboratory is the detection of plasmodia in peripheral blood with the help of the “thick blood film” after Giemsa staining. The RIDA®QUICK Malaria rapid test is a quick alternative that can also be performed by persons without special training. The test can also be used as a screening method for serial examinations in blood banks. In the event of microscopically uncertain parasite morphology or parasite morphology that can be difficult to assess, the test can also be used as a confirmatory test for malaria. The RIDA®QUICK Malaria rapid test is also very suited for treatment monitoring because it can detect the reduction of plasmodia antigens still circulating in the blood, even if the plasmodia morphology of the different blood stages in the blood smear is no longer recognisable under the microscope. Nevertheless, the definitive diagnosis of malaria is based on the microscopic examination of the blood, supported by further additional laboratory parameters in conjunction with the clinical diagnosis of the patient.

Accessories:

Specifications
Art. No. N7006/N7007
Incubation time 30 min
Detection limit 45 Plasmodia /µl for P. falciparum
100 Plasmodia /µl for P.vivax
Sensitivity 97,7 %
Specificity > 99,0 %
Files
InstructionsGerman
French
Italian
Spanish
Portuguese
English
SDSN7007_german.zip (German)
N7007_english.zip (English)
(French)
N7006_spanish-1.zip (Spanish)
Similar Products
RIDASCREEN® Zika Virus IgG capture, IgM µ-capture
RIDASCREEN® Zika Virus IgG ...
For in vitro diagnostic use. The RIDASCREEN® Zika Virus tests are enzyme immunoassays for the qualitative detection of IgG or IgM antibodies to the...
RIDASCREEN® Malaria Ab-Screening
RIDASCREEN® Malaria Ab-Scre...
For in vitro diagnostic use. The RIDASCREEN® Malaria Ab-Screening test is an enzyme immunoassay for the qualitative detection of IgG and IgM antibo...
RIDASCREEN® Dengue Virus IgG, IgM µ-capture
RIDASCREEN® Dengue Virus Ig...
For in vitro diagnostic use. The RIDASCREEN® Dengue Virus tests are enzyme immunoassays for the qualitative detection of IgG or IgM antibodies to t...

Start typing and press Enter to search

n8003_rq-legionellapositive control